Moderna Aktie
50,70
EUR
+0,41
EUR
+0,82
%
58,70
USD
+0,79
USD
+1,36
%
nachbörslich
Moderna jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Moderna Aktie Analyse
| 12.01.24 | Moderna Outperform | RBC Capital Markets | |
| 03.11.23 | Moderna Buy | Goldman Sachs Group Inc. | |
| 02.11.23 | Moderna Buy | UBS AG | |
| 23.10.23 | Moderna Buy | UBS AG | |
| 17.02.23 | Moderna Buy | Goldman Sachs Group Inc. | |
| 16.09.21 | Moderna Buy | Goldman Sachs Group Inc. | |
| 07.05.21 | Moderna overweight | Barclays Capital | |
| 11.12.20 | Moderna buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 29.07.20 | Moderna buy | Goldman Sachs Group Inc. | |
| 27.07.20 | Moderna buy | Goldman Sachs Group Inc. | |
| 05.04.19 | Moderna Buy | Chardan Capital Markets | |
| 02.01.19 | Moderna overweight | Barclays Capital | |
| 02.01.19 | Moderna Buy | Needham & Company, LLC | |
Werbung
Werbung